| NDC Code | 14537-408-50 |
|---|
| Package Description | 18 CONTAINER in 1 CASE (14537-408-50) > 500 mL in 1 CONTAINER |
|---|
| Product NDC | 14537-408 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Isoplate |
|---|
| Non-Proprietary Name | Sodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride, Magnesium Chloride, Sodium Phosphate, Dibasic, And Potassium Phosphate, Monobasic |
|---|
| Dosage Form | SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20130305 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | BN090067 |
|---|
| Manufacturer | Terumo BCT Ltd. |
|---|
| Substance Name | MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE; SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM |
|---|
| Strength | .03; .037; .00082; .37; .53; .5; .008 |
|---|
| Strength Unit | g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL |
|---|
| Pharmacy Classes | Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] |
|---|